Bloodscan Life Technology CO., LTD.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Labyrinth microfluidic chip has been applied in various academic and clinical studies to enable downstream applications through its high CTC purity, viability, recovery, and unbiased enrichment.
Founded Year
2023
Unified Business No.
94010229
Status
Active
Number of Employees
0
Total Paid-in
Capital
8,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BloodScan Biotech transforms cancer care with Labyrinth One, the world’s first liquid biopsy system comparable to tissue biopsy. We enable earlier, more precise, and more personalized detection and monitoring of cancer.
